Squawk on the Street cover image

SOTS 2nd Hour: Israel-Iran Conflict Latest, G-7 Meeting Begins, & FOMC Predictions 6/16/25

Squawk on the Street

00:00

Sarepta Therapeutics Faces Major Setbacks Amid Safety Concerns

This chapter explores the sharp decline in Sarepta Therapeutics' stock following patient fatalities linked to their gene therapy for Duchenne muscular dystrophy. It examines the implications of the FDA's decision to broaden approval criteria and the company's response to safety concerns amid changing sales forecasts.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app